跳至主要内容
临床试验/NCT04165226
NCT04165226已完成不适用

Low Level Light Therapy and Fractional Carbon Dioxide Laser in the Treatment of Stria Alba: A Randomised Controlled Study

Kasr El Aini Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2018年11月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Comparative effectiveness of the 3 intervention groups as assessed by patient global assessment at month 3 (End of study)

研究概览

简要总结

Stria alba (aka white or atrophic stretch marks) is a very common dermatologic condition that causes major psychological distress to those afflicted. We study the effect of low level light therapy using infra red diode 808/915 nm laser in comparison to fractional CO2 alone and combined both therapies.

详细描述

All patients will be subjected to the following:

  • Written informed consent.
  • Detailed history and clinical evaluation.

The treated areas will be photographed (in standardized settings of light and position) and measured in order to allow comparison and assessment of striae improvement following treatment.

Patients will be allocated according to randomization into one of 3 arms:

Arm A will be treated by fractional CO2 laser. Arm B will be treated by low level light therapy (LLLT). Arm C will be treated with a combination of fractional CO2 laser and LLLT.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects, above the age of 18 years old, with stria alba.
  • Both genders.

排除标准

  • Pregnant or lactating females.
  • Subjects who were treated with any interventional procedure (lasers, radiofrequency, dermabrasion, microdermabrasion, or chemical peeling) within 6 months prior to the study.
  • Subjects who applied topical corticosteroids, retinoid, vitamin C, or vitamin E within 3 months prior to the study.
  • Subjects who orally took retinoids or corticosteroids within 3 months.
  • Subjects who had a history of hypertrophic scar, keloid or immunosuppression or cancer.

结局指标

主要结局

Comparative effectiveness of the 3 intervention groups as assessed by patient global assessment at month 3 (End of study)

时间窗: 3 months

Patients will be assessed before and after treatment by one unblinded and one blinded investigators to measure the clinical improvement on a 4-point scale by comparing the photographs. The criteria for evaluation using a quartile grading scale will be as follows; 0=no improvement, 1=mild improvement (\<25%), 2=moderate improvement (26% - 50%), 3=good improvement (51% -75%), 4=excellent improvement (\>76%).

Comparative effectiveness of the 3 intervention groups as assessed by patient satisfaction score at month 3 (End of study)

时间窗: 3 months

Patient satisfaction score will be rated using the following scale; 0=not satisfied, 1=slightly satisfied, 2= satisfied, 3=very satisfied, 4=extremely satisfied as well as patients' satisfaction questionnaire

Comparative effectiveness of the 3 intervention groups as assessed by physician global assessment at month 3 (End of study)

时间窗: 3 months

Patients will be assessed before and after treatment by one unblinded and one blinded investigators to measure the clinical improvement on a 4-point scale by comparing the photographs. The criteria for evaluation using a quartile grading scale will be as follows; 0=no improvement, 1=mild improvement (\<25%), 2=moderate improvement (26% - 50%), 3=good improvement (51% -75%), 4=excellent improvement (\>76%).

次要结局

  • Comparative effectiveness of the 3 intervention groups as assessed by patient global assessment at month 1(1 month)
  • Comparative effectiveness of the 3 intervention groups as assessed by patient satisfaction score at month 1(1 month)
  • Comparative tolerability of the 3 intervention groups as assessed by the incidence of side effects (edema, pain, erythema, itching, peeling)(3 months)
  • Comparative effectiveness of the 3 intervention groups as assessed by physician global assessment at month 1(1 month)
  • Comparative tolerability of the fractional CO2 versus combined fractional and LLLT as regards duration of side effects in days after each laser session (edema, pain, erythema, itching, peeling)(3 months)

研究者

发起方
Kasr El Aini Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Marina Mikhail

Visiting resident

Kasr El Aini Hospital

研究点 (1)

Loading locations...

相似试验